Oculis Holding AG Ordinary shares (OCS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $425.11M
Last updated: Nov 17, 2026 at 4:10 PM ET
Oculis Holding AG Ordinary shares (OCS) Statistics
Oculis Holding AG Ordinary shares (OCS) has a market cap of $425.11M. It kept -1157669.73% of revenue as net income over the last 12 months. Revenue fell 98.61% over the last 12 months from the 12 months before.
Total Valuation
| Market Cap | $425.11M |
|---|---|
| Latest price (Nov 17, 2026) | $7.51 |
Key Dates
| Last Earnings Date | Nov 3, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
| P/B Ratio | 1.9x |
|---|---|
| P/TBV Ratio | 2.0x |
Price Statistics
The stock is down 61.68% over 52 weeks and trades 12.27% below its 50-day average.
| Beta (1Y) | 1.06 |
|---|---|
| 52-Week Change | -61.68% |
| 1-Month Change | +2.60% |
| 3-Month Change | -44.66% |
| 6-Month Change | -73.14% |
| Total Return (1Y) | -61.68% |
| Total Return (3Y CAGR) | -8.21% |
| Return vs SPY (1Y) | -72.63% |
| Max Drawdown (1Y) | -79.08% |
| Max Drawdown (3Y) | -79.08% |
| Sharpe Ratio (1Y) | -1.28 |
| Correlation with SPY (1Y) | 0.20 |
| 50-Day Average | $8.56 |
| 200-Day Average | $17.65 |
| 52-Week Range | $6.78 to $34.48 |
| RSI (14 Days) | 42.4 |
| Average Volume (20 Days) | 305.94K |
Financial Position
Current assets cover 10.41x current liabilities.
| Current Ratio | 10.41x |
|---|---|
| Quick Ratio | 10.41x |
| Interest Coverage | -73.78x |
Returns and Efficiency
Return on equity is -40.24% and return on assets is -36.16% over the last 12 months.
| Return on Equity (ROE) | -40.24% |
|---|---|
| Return on Assets (ROA) | -36.16% |
| Return on Capital Employed (ROCE) | -37.92% |
| ROA (5Y Average) | -65.06% |
| ROIC (5Y Average) | -82.69% |
| Asset Turnover | 0.00x |
Scores
OCS has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was CHF 7.00K over the last 12 months.
| Revenue | CHF 7.00K |
|---|---|
| Revenue Growth (YoY) | -98.61% |
| Operating Income | CHF -90.52M |
| Pretax Income | CHF -81.35M |
| Net Income | CHF -81.04M |
| EBITDA | CHF -79.49M |
| EBIT | CHF -80.26M |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 89.85% of the CHF 232.32M in total assets.
| Working Capital | CHF 194.18M |
|---|---|
| Shareholder Equity | CHF 208.75M |
| Tangible Book Value | CHF 195.46M |
| Total Assets | CHF 232.32M |
| Total Liabilities | CHF 23.57M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | CHF -71.41M |
|---|---|
| Depreciation and Amortization | CHF 764.43K |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -1293091.53%.
| Operating Margin | -1293091.53% |
|---|---|
| Pretax Margin | -1162195.49% |
| Net Margin | -1157669.73% |
| EBITDA Margin | -1135617.49% |
| EBIT Margin | -1146537.97% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About OCS
What is OCS's market cap?
Oculis Holding AG Ordinary shares has a market cap of $425.11M.
How many shares of OCS are outstanding?
Oculis Holding AG Ordinary shares has 61.82M shares outstanding. The count is up 17.36% from a year earlier.
Does OCS pay a dividend?
No. Oculis Holding AG Ordinary shares does not pay a dividend.
OCS pages: Overview, Charting, Financials, Statistics, Competitors